002422.SZ
Sichuan Kelun Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 39.56
−0.70%Year over year
Reported trailing growth
- Revenue
- -8.0%
- EBITDA
- —
- EBIT
- -41.9%
- EPS
- -37.4%
- Free cash flow
- -61.1%
- Operating cash flow
- -33.3%
Forward estimates
Based on analyst estimates
- Revenue
- -8.7%
- EBITDA
- -2.7%
- EPS
- +25.8%
Three-year CAGR
- Revenue
- -0.9%
- EBITDA
- +4.7%
- EBIT
- +4.7%
- Net income
- -0.1%
- EPS
- -4.3%
- Free cash flow
- -23.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026